Exchange: NASDAQ·Updated 07:45 PM EST

FBLG FibroBiologics Inc

$0.705
$0.125
(15.06%)
Today
Closed $0.705
$0.017
(2.41%)
After Hours
Reported EarningsNov 16
Mkt Cap$6.34M
Vol50,345.00

About FBLG

FibroBiologics, Inc. engages in the development and commercialization of cell therapies. It focuses on treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. The firm’s product pipeline includes CybroCell, CYMS101, CYWC628, TCB190, and CYTER915. The company was founded by Peter O’Heeron on April 8, 2021 and is headquartered in Houston, TX.
46

Neutral Sentiment

How do you feel about FBLG?

Biotechff
🚀 $FBLG — FibroBiologics: A Regenerative Medicine Company Worth Watching Recent preclinical research into spinal disc regeneration highlights the potential of fibroblast-based therapies. The company is also developing treatments for chronic wounds and other serious conditions. Could FBLG become a major player in regenerative medicine? My personal long-term bull-case target is €200 per share, but this is highly speculative and not supported by a validated valuation model. Clinical results, financing, dilution and regulatory approvals will determine the outcome. High risk. Significant scientific potential. #FBLG #Biotech #RegenerativeMedicine
3
idkmikes57
$FBLG wait till after the first of the year, you'll get it really cheap. This is one of my tax loss 2026!!
1
idkmikes57
$FBLG healthcare soaring, everybody wants in. What about this? Even the dems can't help it.!!

Advertisement|Remove ads.